DDIT3 and Parkinson disease: In addition, the drug Adaptaquin blocks Tribbles pseudokinase 3 (Trib3) induction by inhibiting ATF4 and CHOP activity probably through an eIF2α-independent mechanism, leading to neuronal protection in mouse models of PD (Figure 1, Table 2).